Operating Lease, Liability of Intra-Cellular Therapies, Inc. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Intra-Cellular Therapies, Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Operating Lease, Liability for the quarter ending 31 Dec 2024 was $16,981,000, a 0.25% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $16,981,000 +$43,000 +0.25% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $17,709,000 +$234,000 +1.3% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $18,288,000 +$298,000 +1.7% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $16,376,000 -$2,116,000 -11% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $16,938,000 -$3,103,000 -15% 31 Dec 2023 10-K 22 Feb 2024 2023 FY
Q3 2023 $17,475,000 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $17,990,000 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $18,492,000 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $20,041,000 -$5,366,000 -21% 31 Dec 2022 10-K 01 Mar 2023 2022 FY
Q4 2021 $25,407,000 -$3,693,000 -13% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $26,400,000 -$2,700,000 -9.3% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $27,300,000 +$2,200,000 +8.8% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $28,200,000 +$5,300,000 +23% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $29,100,000 +$5,957,379 +26% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $29,100,000 +$6,543,469 +29% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $25,100,000 +$2,269,258 +9.9% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $22,900,000 -$832,111 -3.5% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $23,142,621 31 Dec 2019 10-K 02 Mar 2020 2019 FY
Q3 2019 $22,556,531 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $22,830,742 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $23,732,111 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.